Therapeutic Drug Monitoring Market by Product (Consumable, Equipment (Immunoassay analyzer)), Technology (Fluorescence Immunoassay, Radioimmunoassay, GCMS), Class of drugs (Antibiotics, Bronchodilators), End User (Hospital Lab) - Global Forecast to 2023
By: marketsandmarkets.com
Publishing Date: August 2018
Report Code: MD 4185
The therapeutic drug monitoring market is projected to reach to reach USD 1.63 billion by 2023 from USD 1.16 billion in 2017 at a CAGR of 5.9% during the forecast period. The scope of the study includes the various consumables and equipments used to perform therapeutic drug monitoring assays. The base year considered for the study is 2017, and the forecast for the market size is provided for the period between 2018 and 2023.
Objectives of the Study
- To define, describe, and forecast the therapeutic drug monitoring market on the basis of technology, product, class of drug, end user, and regions
- To provide detailed information about factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges)
- To strategically analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the market segments with respect to four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW)
- To profile the key players in the market and comprehensively analyze their market positions and core competencies
- To track and analyze competitive developments such as mergers and acquisitions; product development; and research and development activities in the therapeutic drug monitoring market
Research Methodology
Top-down and bottom-up approaches were used to validate the size of the global therapeutic drug monitoring market and estimate the size of various other dependent submarkets. Major players in the market were identified through secondary research and their market presence was studied through primary and secondary research. Secondary research included the study of the annual and financial reports of top market players, white papers, medical journals, certified publications, articles from recognized authors, directories, databases such as WHO, OECD, American Association for Clinical Chemistry (AACC), European Federation of Pharmaceutical Industries and Associations (EFPIA), International Trade Association, NCBI, and National Health Service (NHS). Primary research included extensive interviews with key opinion leaders such as CEOs, directors, and marketing executives. The percentage splits, shares, and breakdowns of the segments were determined using secondary sources and verified through primary sources. This data is consolidated and added to detailed inputs and analysis from MarketsandMarkets and presented in this report.
To know about the assumptions considered for the study, download the pdf brochure
The key players operating in the therapeutic drug monitoring market are F. Hoffmann-La Roche (Switzerland), Siemens Healthineers (Germany), and Abbott (US).
Target Audience:
- Government and academic institutes
- Therapeutic drug monitoring providers
- R&D departments
- Contract research organizations
- Pharmaceutical & biotechnology companies
- Consulting firms
- Government associations
Scope of the Report
The research report categorizes the global therapeutic drug monitoring market into the following segments and subsegments:
Therapeutic Drug Monitoring Market, by Product
- Consumables
- Equipment
- Immunoassay Analyzers
- Chromatography & MS
- Clinical Chemistry Analyzers
Therapeutic Drug Monitoring Market, by Class of Drugs
- Antiepileptic Drugs
- Antiarrhythmic Drugs
- Immunosuppressant Drugs
- Antibiotic Drugs
- Bronchodilator Drugs
- Psychoactive Drugs
- Other Drug Classes
Therapeutic Drug Monitoring Market, by Technology
- Immunoassays
- Chemiluminescent Immunoassay (CLIA)
- Fluorescence Immunoassay (FPIA)
- Radioimmunoassay (RIA)
- Colorimetry Immunoassay
- Others Immunoassay
Chromatography & Mass Spectroscopy
- Gas Chromatography/Mass Spectrometry (GC-MS)
- Liquid Chromatography/Mass Spectrometry (LC-MS)
Therapeutic Drug Monitoring Market, by End User
- Commercial/Private Labs
- Hospital Labs
- Other End Users (Academic Institutes and Research Universities)
Therapeutic Drug Monitoring Market, by Region
- North America
- US
- Canada
- Europe
- Asia Pacific
- Japan
- China
- India
- RoAPAC
- Rest of the World (RoW)
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the companys specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to 5)
Table of Contents
1 Introduction (Page No. - 15)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Market Covered
1.3.2 Years Covered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology (Page No. - 18)
2.1 Research Data
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.3.1 Key Data Sources From Secondary Sources
2.3.2 Key Data From Primary Sources
2.3.2.1 Key Industry Insights
3 Executive Summary (Page No. - 25)
4 Premium Insights (Page No. - 28)
4.1 Therapeutic Drug Monitoring (TDM): Market Overview
4.2 Asia Pacific: Therapeutic Drug Monitoring Market, By Class of Drug
4.3 Geographic Mix: Therapeutic Drug Monitoring Market
4.4 Therapeutic Drug Monitoring Market, By End User
5 Market Overview (Page No. - 31)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Use of TDM in Traditional Anticancer Therapies
5.2.1.2 Rising Number of Organ Transplant Procedures
5.2.2 Restraints
5.2.2.1 Reluctance of Small Hospitals to Offer TDM Services
5.2.3 Opportunities
5.2.3.1 Monitoring of Biosimilars in Autoimmune Diseases
5.2.4 Challenges
5.2.4.1 Operational Barriers Faced in Conducting TDM Tests
6 Therapeutic Drug Monitoring Market, By Product (Page No. - 34)
6.1 Introduction
6.2 Consumables
6.3 Equipment
6.3.1 Immunoassay Analyzers
6.3.2 Chromatography and MS Detectors
6.3.3 Clinical Chemistry Analyzers
7 Therapeutic Drug Monitoring Market, By Technology (Page No. - 42)
7.1 Introduction
7.2 Immunoassays
7.2.1 Chemiluminescent Immunoassays
7.2.2 Fluorescence Immunoassays
7.3 Colorimetric Immunoassays
7.4 Radioimmunoassays
7.5 Other Immunoassays
7.6 Chromatography-MS
7.6.1 Liquid Chromatography/Mass Spectrometry (LC-MS)
7.6.2 Gas Chromatography-Mass Spectrometry
8 Therapeutic Drug Monitoring Market, By Class of Drug (Page No. - 58)
8.1 Introduction
8.2 Antiepileptic Drugs
8.3 Antiarrhythmic Drugs
8.4 Immunosuppressant Drugs
8.5 Antibiotic Drugs
8.6 Bronchodilator Drugs
8.7 Psychoactive Drugs
8.8 Other Drug Classes
9 Therapeutic Drug Monitoring Market, By End User (Page No. - 70)
9.1 Introduction
9.2 Hospital Laboratories
9.3 Commercial/Private Laboratories
9.4 Other End Users
10 Therapeutic Drug Monitoring Market, By Region (Page No. - 77)
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.3 Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 RoAPAC
10.5 Rest of the World
11 Competitive Landscape (Page No. - 112)
11.1 Introduction
11.2 Market Ranking Analysis
11.3 Competitive Situation and Trends
11.3.1 Product Launches
11.3.2 Mergers & Acquisitions
12 Company Profiles (Page No. - 114)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 Abbott Laboratories
12.2 F. Hoffmann-La Roche
12.3 Siemens Healthineers
12.4 Thermo Fisher Scientific
12.5 Danaher Corporation
12.6 Bio-Rad Laboratories
12.7 Biomιrieux
12.8 Bόhlmann Laboratories
12.9 Sekisui Medical
12.10 Randox Laboratories
*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.
13 Appendix (Page No. - 135)
13.1 Discussion Guide
13.2 Knowledge Store: Marketsandmarkets Subscription Portal
13.3 Available Customizations
13.4 Related Reports
13.5 Author Details
List of Tables (145 Tables)
Table 1 Therapeutic Drug Monitoring Market, By Product, 20162023 (USD Million)
Table 2 Therapeutic Drug Monitoring Consumables Market, By Region, 20162023 (USD Million)
Table 3 North America: Therapeutic Drug Monitoring Consumables Market, By Country, 20162023 (USD Million)
Table 4 Asia Pacific: Therapeutic Drug Monitoring Consumables Market, By Country, 20162023 (USD Million)
Table 5 Therapeutic Drug Monitoring Equipment Market, By Region, 20162023 (USD Million)
Table 6 North America: Therapeutic Drug Monitoring Equipment Market, By Country, 20162023 (USD Million)
Table 7 Asia Pacific: Therapeutic Drug Monitoring Equipment Market, By Country, 20162023 (USD Million)
Table 8 Therapeutic Drug Monitoring Equipment Market, By Type, 20162023 (USD Million)
Table 9 Therapeutic Drug Monitoring Market for Immunoassay Analyzers, By Region, 20162023 (USD Million)
Table 10 Therapeutic Drug Monitoring Market for Chromatography and MS Detectors, By Region, 20162023 (USD Million)
Table 11 Therapeutic Drug Monitoring Market for Clinical Chemistry Analyzers, By Region, 20162023 (USD Million)
Table 12 Therapeutic Drug Monitoring Market, By Technology, 20162023 (USD Million)
Table 13 Therapeutic Drug Monitoring Immunoassays Market, By Type, 20162023 (USD Million)
Table 14 Therapeutic Drug Monitoring Immunoassays Market, By Region, 20162023 (USD Million)
Table 15 North America: Therapeutic Drug Monitoring Immunoassays Market, By Country, 20162023 (USD Million)
Table 16 Asia Pacific: Therapeutic Drug Monitoring Immunoassays Market, By Country, 20162023 (USD Million)
Table 17 Clia Systems Available in the Market
Table 18 Chemiluminescent Immunoassays Market, By Region, 20162023 (USD Million)
Table 19 North America: Chemiluminescent Immunoassays Market, By Country, 20162023 (USD Million)
Table 20 Asia Pacific: Chemiluminescent Immunoassays Market, By Country, 20162023 (USD Million)
Table 21 Fluorescence Immunoassays Market, By Region, 20162023 (USD Million)
Table 22 North America: Fluorescence Immunoassays Market, By Country, 20162023 (USD Million)
Table 23 Asia Pacific: Fluorescence Immunoassays Market, By Country, 20162023 (USD Million)
Table 24 Colorimetric Immunoassays Market, By Region, 20162023 (USD Million)
Table 25 North America: Colorimetric Immunoassays Market, By Country, 20162023 (USD Million)
Table 26 Asia Pacific: Colorimetric Immunoassays Market, By Country, 20162023 (USD Million)
Table 27 Radioimmunoassays Market, By Region, 20162023 (USD Million)
Table 28 North America: Radioimmunoassays Market, By Country, 20162023 (USD Million)
Table 29 Asia Pacific: Radioimmunoassays Market, By Country, 20162023 (USD Million)
Table 30 Other Immunoassays Market, By Region, 20162023 (USD Million)
Table 31 North America: Other Immunoassays Market, By Country, 20162023 (USD Million)
Table 32 Asia Pacific: Other Immunoassays Market, By Country, 20162023 (USD Million)
Table 33 Therapeutic Drug Monitoring Chromatography-MS Market, By Type, 20162023 (USD Million)
Table 34 Therapeutic Drug Monitoring Chromatography-MS Market, By Region, 20162023 (USD Million)
Table 35 North America: Therapeutic Drug Monitoring Chromatography-MS Market, By Country, 20162023 (USD Million)
Table 36 Asia Pacific: Therapeutic Drug Monitoring Chromatography-MS, By Country, 20162023 (USD Million)
Table 37 Liquid Chromatography-Mass Spectrometry Market, By Region, 20162023 (USD Million)
Table 38 North America: Liquid Chromatography-Mass Spectrometry Market, By Country, 20162023 (USD Million)
Table 39 Asia Pacific: Liquid Chromatography-Mass Spectrometry Market, By Country, 20162023 (USD Million)
Table 40 Gas Chromatography-Mass Spectrometry Market, By Region, 20162023 (USD Million)
Table 41 North America: Gas Chromatography-Mass Spectrometry Market, By Country, 20162023 (USD Million)
Table 42 Asia Pacific: Gc-MS Market, By Country, 20162023 (USD Million)
Table 43 Therapeutic Drug Monitoring Market, By Class of Drug, 20162023 (USD Million)
Table 44 Guidelines for the Monitoring of Antiepileptic Drugs
Table 45 Antiepileptic Drugs Monitoring Market, By Region, 20162023 (USD Million)
Table 46 North America: Antiepileptic Drugs Monitoring Market, By Country, 20162023 (USD Million)
Table 47 Asia Pacific: Antiepileptic Drugs Monitoring Market, By Country, 20162023 (USD Million)
Table 48 Antiarrhythmic Drugs Monitoring Market, By Region, 20162023 (USD Million)
Table 49 North America: Antiarrhythmic Drugs Monitoring Market, By Country, 20162023 (USD Million)
Table 50 Asia Pacific: Antiarrhythmic Drugs Monitoring Market, By Country, 20162023 (USD Million)
Table 51 Immunosuppressant Drugs Monitoring Market, By Region, 20162023 (USD Million)
Table 52 North America: Immunosuppressant Drugs Monitoring Market, By Country, 20162023 (USD Million)
Table 53 Asia Pacific: Immunosuppressant Drugs Monitoring Market, By Country, 20162023 (USD Million)
Table 54 Antibiotic Drugs Monitoring Market, By Region, 20162023 (USD Million)
Table 55 North America: Antibiotic Drugs Monitoring Market, By Country, 20162023 (USD Million)
Table 56 Asia Pacific: Antibiotic Drugs Monitoring Market, By Country, 20162023 (USD Million)
Table 57 Therapeutic Ranges for Bronchodilators
Table 58 Bronchodilator Drugs Monitoring Market, By Region, 20162023 (USD Million)
Table 59 North America: Bronchodilator Drugs Monitoring Market, By Country, 20162023 (USD Million)
Table 60 Asia Pacific: Bronchodilator Drugs Monitoring Market, By Country, 20162023 (USD Million)
Table 61 Psychoactive Drugs Monitoring Market, By Region, 20162023 (USD Million)
Table 62 North America: Psychoactive Drugs Monitoring Market, By Country, 20162023 (USD Million)
Table 63 Asia Pacific: Psychoactive Drugs Monitoring Market, By Country, 20162023 (USD Million)
Table 64 Other Drugs Monitoring Market, By Region, 20162023 (USD Million)
Table 65 North America: Other Drugs Monitoring Market, By Country, 20162023 (USD Million)
Table 66 Asia Pacific: Other Drugs Monitoring Market, By Country, 20162023 (USD Million)
Table 67 Therapeutic Drug Monitoring Market, By End User, 20162023 (USD Million)
Table 68 Therapeutic Drug Monitoring Market for Hospital Laboratories, By Region, 2016-2023 (USD Million)
Table 69 North America: Therapeutic Drug Monitoring for Hospital Laboratories, By Country, 20162023 (USD Million)
Table 70 Asia Pacific: Therapeutic Drug Monitoring for Hospital Laboratories, By Country, 20162023 (USD Million)
Table 71 Therapeutic Drug Monitoring Market for Commercial/Private Laboratories, By Region, 2013-2023 (USD Million)
Table 72 North America: Therapeutic Drug Monitoring for Commercial/ Private Laboratories, By Country, 20162023 (USD Million)
Table 73 Asia Pacific: Therapeutic Drug Monitoring for Commercial/ Private Laboratories, By Country, 20162023 (USD Million)
Table 74 Therapeutic Drug Monitoring Market for Other End Users, By Region, 2016-2023 (USD Million)
Table 75 North America: Therapeutic Drug Monitoring for Other End Users, By Country, 20162023 (USD Million)
Table 76 Asia Pacific: Therapeutic Drug Monitoring for Other End Users, By Country, 20162023 (USD Million)
Table 77 Therapeutic Drug Monitoring Market, By Region, 20162023 (USD Million)
Table 78 North America: Therapeutic Drug Monitoring Market, By Country, 20162023 (USD Million)
Table 79 North America: Therapeutic Drug Monitoring Market, By Product, 20162023 (USD Million)
Table 80 North America: Therapeutic Drug Monitoring Equipment Market, By Type, 20162023 (USD Million)
Table 81 North America: Therapeutic Drug Monitoring Market, By Technology, 20162023 (USD Million)
Table 82 North America: Therapeutic Drug Monitoring Immunoassays Market, By Type, 20162023 (USD Million)
Table 83 North America: Therapeutic Drug Monitoring Chromatography & MS Market, By Type, 20162023 (USD Million)
Table 84 North America: Therapeutic Drug Monitoring Market, By Class of Drug, 20162023 (USD Million)
Table 85 North America: Therapeutic Drug Monitoring Market, By End User, 20162023 (USD Million)
Table 86 US: Therapeutic Drug Monitoring Market, By Product, 20162023 (USD Million)
Table 87 US: Therapeutic Drug Monitoring Market, By Technology, 20162023 (USD Million)
Table 88 US: Therapeutic Drug Monitoring Immunoassays Market, By Type, 20162023 (USD Million)
Table 89 US: Therapeutic Drug Monitoring Chromatography & MS Market, By Type, 20162023 (USD Million)
Table 90 US: Therapeutic Drug Monitoring Market, By Class of Drug, 20162023 (USD Million)
Table 91 US: Therapeutic Drug Monitoring Market, By End User, 20162023 (USD Million)
Table 92 Canada: Therapeutic Drug Monitoring Market, By Product, 20162023 (USD Million)
Table 93 Canada: Therapeutic Drug Monitoring Market, By Technology, 20162023 (USD Million)
Table 94 Canada: Therapeutic Drug Monitoring Immunoassays Market, By Type, 20162023 (USD Million)
Table 95 Canada: Therapeutic Drug Monitoring Chromatography & MS Market, By Type, 20162023 (USD Million)
Table 96 Canada: Therapeutic Drug Monitoring Market, By Class of Drug, 20162023 (USD Million)
Table 97 Canada: Therapeutic Drug Monitoring Market, By End User, 20162023 (USD Million)
Table 98 Europe: Therapeutic Drug Monitoring Market, By Product, 20162023 (USD Million)
Table 99 Europe: Therapeutic Drug Monitoring Equipment Market, By Type, 20162023 (USD Million)
Table 100 Europe: Therapeutic Drug Monitoring Market, By Technology, 20162023 (USD Million)
Table 101 Europe: Therapeutic Drug Monitoring Immunoassays Market, By Type, 20162023 (USD Million)
Table 102 Europe: Therapeutic Drug Monitoring Chromatography & MS Market, By Type, 20162023 (USD Million)
Table 103 Europe: Therapeutic Drug Monitoring Market, By Class of Drug, 20162023 (USD Million)
Table 104 Europe: Therapeutic Drug Monitoring Market, By End User, 20162023 (USD Million)
Table 105 Asia Pacific: Therapeutic Drug Monitoring Market, By Country, 20162023 (USD Million)
Table 106 Asia Pacific: Therapeutic Drug Monitoring Market, By Product, 20162023 (USD Million)
Table 107 Asia Pacific: Therapeutic Drug Monitoring Equipment Market, By Type, 20162023 (USD Million)
Table 108 Asia Pacific: Therapeutic Drug Monitoring Market, By Technology, 20162023 (USD Million)
Table 109 Asia Pacific: Therapeutic Drug Monitoring Immunoassays Market, By Type, 20162023 (USD Million)
Table 110 Asia Pacific: Therapeutic Drug Monitoring Chromatography & MS Market, By Type, 20162023 (USD Million)
Table 111 Asia Pacific: Therapeutic Drug Monitoring Market, By Class of Drug, 20162023 (USD Million)
Table 112 Asia Pacific: Therapeutic Drug Monitoring Market, By End User, 20162023 (USD Million)
Table 113 Japan: Therapeutic Drug Monitoring Market, By Product, 20162023 (USD Million)
Table 114 Japan: Therapeutic Drug Monitoring Market, By Technology, 20162023 (USD Million)
Table 115 Japan: Therapeutic Drug Monitoring Immunoassays Market, By Type, 20162023 (USD Million)
Table 116 Japan: Therapeutic Drug Monitoring Chromatography & MS Market, By Type, 20162023 (USD Million)
Table 117 Japan: Therapeutic Drug Monitoring Market, By Class of Drug, 20162023 (USD Million)
Table 118 Japan: Therapeutic Drug Monitoring Market, By End User, 20162023 (USD Million)
Table 119 China: Therapeutic Drug Monitoring Market, By Product, 20162023 (USD Million)
Table 120 China: Therapeutic Drug Monitoring Market, By Technology, 20162023 (USD Million)
Table 121 China: Therapeutic Drug Monitoring Immunoassays Market, By Type, 20162023 (USD Million)
Table 122 China: Therapeutic Drug Monitoring Chromatography & MS Market, By Type, 20162023 (USD Million)
Table 123 China: Therapeutic Drug Monitoring Market, By Class of Drug, 20162023 (USD Million)
Table 124 China: Therapeutic Drug Monitoring Market, By End User, 20162023 (USD Million)
Table 125 India: Therapeutic Drug Monitoring Market, By Product, 20162023 (USD Million)
Table 126 India: Therapeutic Drug Monitoring Market, By Technology, 20162023 (USD Million)
Table 127 India: Therapeutic Drug Monitoring Immunoassays Market, By Type, 20162023 (USD Million)
Table 128 India: Therapeutic Drug Monitoring Chromatography & MS Market, By Type, 20162023 (USD Million)
Table 129 India: Therapeutic Drug Monitoring Market, By Class of Drug, 20162023 (USD Million)
Table 130 India: Therapeutic Drug Monitoring Market, By End User, 20162023 (USD Million)
Table 131 RoAPAC: Therapeutic Drug Monitoring Market, By Product, 20162023 (USD Million)
Table 132 RoAPAC: Therapeutic Drug Monitoring Market, By Technology, 20162023 (USD Million)
Table 133 RoAPAC: Therapeutic Drug Monitoring Immunoassays Market, By Type, 20162023 (USD Million)
Table 134 RoAPAC: Therapeutic Drug Monitoring Chromatography & MS Market, By Type, 20162023 (USD Million)
Table 135 RoAPAC: Therapeutic Drug Monitoring Market, By Class of Drug, 20162023 (USD Million)
Table 136 RoAPAC: Therapeutic Drug Monitoring Market, By End User, 20162023 (USD Million)
Table 137 RoW: Therapeutic Drug Monitoring Market, By Product, 20162023 (USD Million)
Table 138 RoW: Therapeutic Drug Monitoring Equipment Market, By Type, 20162023 (USD Million)
Table 139 RoW: Therapeutic Drug Monitoring Market, By Technology, 20162023 (USD Million)
Table 140 RoW: Therapeutic Drug Monitoring Immunoassays Market, By Type, 20162023 (USD Million)
Table 141 RoW: Therapeutic Drug Monitoring Chromatography & MS Market, By Type, 20162023 (USD Million)
Table 142 RoW: Therapeutic Drug Monitoring Market, By Class of Drug, 20162023 (USD Million)
Table 143 RoW: Therapeutic Drug Monitoring Market, By End User, 20162023 (USD Million)
Table 144 Product Launches/Approvals, 20152018
Table 145 Mergers & Acquisitions, 20152018
List of Figures (23 Figures)
Figure 1 Research Design
Figure 2 Therapeutic Drug Monitoring Market: Top-Down Approach
Figure 3 Therapeutic Drug Monitoring Market: Bottom-Up Approach
Figure 4 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Data Triangulation Method
Figure 6 Therapeutic Drug Monitoring Market, By Product, 2018 vs 2023 (USD Billion)
Figure 7 Therapeutic Drug Monitoring Market, By Class of Drug, 2018 vs 2023 (USD Million)
Figure 8 Therapeutic Drug Monitoring Market, By Technology, 2018 vs 2023 (USD Million)
Figure 9 Geographic Snapshot of the Therapeutic Drug Monitoring Market
Figure 10 Growth of This Market is Majorly Driven By the Rising Number of Organ Transplant Procedures
Figure 11 Antiepileptic Drugs Will Dominate the Asia Pacific TDM Class of Drugs Market in 2018
Figure 12 APAC to Grow at the Highest CAGR in the Forecast Period
Figure 13 Therapeutic Drug Monitoring Market: Drivers, Restraints, Opportunities, and Challenges
Figure 14 North America: Therapeutic Drug Monitoring Market Snapshot
Figure 15 Asia Pacific: Therapeutic Drug Monitoring Market Snapshot
Figure 16 Therapeutic Drug Monitoring Market Ranking Analysis, By Key Player, 2017
Figure 17 Abbott Laboratories: Company Snapshot (2017)
Figure 18 Roche Diagnostics: Company Snapshot (2017)
Figure 19 Siemens Healthineers: Company Snapshot (2017)
Figure 20 Thermo Fisher Scientific: Company Snapshot (2017)
Figure 21 Danaher Corporation: Company Snapshot (2017)
Figure 22 Bio-Rad Laboratories: Company Snapshot (2017)
Figure 23 Biomιrieux: Company Snapshot (2017)
The global therapeutic drug monitoring (TDM) market is projected to reach USD 1.63 billion by 2023 from USD 1.23 billion in 2018, at a CAGR of 5.9% during the forecast period. Market growth is largely driven by factors rising number of organ transplant procedures and the use of TDM in traditional anticancer therapies.
In this report, the market has been categorized based on product, class of drugs, technology, end user, and region. On the basis of technology, the therapeutic drug monitoring market is segmented into immunoassay and chromatography & MS. In 2018, the immunoassay segment is expected to account for the largest share of the therapeutic drug monitoring market. The large share of this segment is mainly due to the increasing incidence of chronic and infectious diseases and technological innovation.
On the basis of end user, the therapeutic drug monitoring market is divided into hospital laboratories, commercial/private laboratories, and other end users. Hospital laboratories is expected to account for the largest share of the therapeutic drug monitoring market. The large share of this segment is attributed to the fact that most diagnostic tests are performed in hospitals or hospital-attached laboratories as they have the appropriate equipment as well as skilled staff to deliver clinically meaningful interpretations from TDM assays.
In 2018, North America is expected to account for the largest share of the global therapeutic drug monitoring market, while Asia Pacific is expected to grow at the highest rate during the forecast period. The dominant share of the North American market is attributed to its well-established pharmaceutical industry, the presence of leading pharmaceutical and biotechnology companies, favorable government funding, and high R&D investments in this region.
However, the lack of financial provisions for the clinical interpretation of TDM results is expected to restrain the growth of this market during the forecast period.
The key players operating in the TDM market are F. Hoffmann-La Roche (Switzerland), Siemens Healthineers (Germany), and Abbott (US). A majority of leading players in the TDM market focus on both organic and inorganic growth strategies to maintain and enhance their market share in the TDM market.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
